Iraq vs Western Pacific (WHO region): New cases tested for RR-/MDR-TB
Iraq
100.0%
in 2024
Western Pacific (WHO region)
89.0%
in 2024
Iraq rank
1st
Western Pacific (WHO region) rank
2nd
New cases tested for RR-/MDR-TB over time
- Iraq
- Western Pacific (WHO region)
How they compare
Iraq currently reports 100.0% against 89.0% in Western Pacific (WHO region), a difference of 11.0%.
That makes Iraq's figure about 1.1 times Western Pacific (WHO region)'s.
The two have swapped places 5 times across 17 shared years of data; in 2007 it was Western Pacific (WHO region) ahead.
Iraq ranks 1st and Western Pacific (WHO region) ranks 2nd of 192 countries.
Across the 3 decades both report, Iraq averaged higher in 1 and Western Pacific (WHO region) in 2.
Head to head by decade
| Decade | Iraq | Western Pacific (WHO region) | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 0.0% | 0.7% | 0.7% | Western Pacific (WHO region) |
| 2010s | 58.0% | 25.9% | 32.1% | Iraq |
| 2020s | 63.1% | 83.2% | 20.1% | Western Pacific (WHO region) |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher new cases tested for rr-/mdr-tb, Iraq or Western Pacific (WHO region)?
- Iraq, at 100.0% against 89.0% in Western Pacific (WHO region) as of 2024.
- What is the difference in new cases tested for rr-/mdr-tb between Iraq and Western Pacific (WHO region)?
- 11.0%, with Iraq ahead.
- How many years of comparable data are there for Iraq and Western Pacific (WHO region)?
- 17 years are reported by both, from 2007 to 2024.
- How do Iraq and Western Pacific (WHO region) rank globally for new cases tested for rr-/mdr-tb?
- Iraq ranks 1st and Western Pacific (WHO region) ranks 2nd of 192 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as New cases tested for RR-/MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.